Maternal Betahistine Exposure and Pregnancy Outcomes: A Retrospective Cohort Study
Abstract
Background In the general population, betahistine has a good safety profile. However, there is insufficient data on betahistine use during pregnancy; safety and teratogenic risks are yet to be evaluated. The study aimed to review pregnancy outcomes in women who were exposed to betahistine during their pregnancies and identify the rate and pattern of major malformation. Material and methods A descriptive retrospective cohort study was conducted. Pregnant women who were prescribed betahistine from Hamad Medical Corporation hospitals between 1st-April-2020 and 31st-March-2022 and had their delivery or abortion at the Women's Wellness and Research Center, Qatar, were included. Patients were followed up until the occurrence of the study outcomes (delivery or abortion), with an additional two months of follow-up for the baby if data were available. Ethical approval was obtained from the Medical Research Center (MRC-01-23-223). Results Forty pregnant women were included, with 42 baby outcomes (including two sets of twins). Betahistine daily dose ranged between 16 mg and 48 mg, with 75% of patients receiving the higher dose of 48 mg. The majority of patients received betahistine during the first trimester (90%) and for a short duration of ≤ 14 days (80%). Six pregnancies ended with spontaneous miscarriage (14.3%), and 34 pregnancies resulted in 36 live babies (85.7%). Four babies (11.1%) were preterm (delivered before 37 weeks of gestation), and four babies had a weight < 2500 g at…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects
- Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study
- Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
- Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.